141 related articles for article (PubMed ID: 37752863)
1. Methotrexate-associated lymphoproliferative disorder presenting as primary cutaneous anaplastic large cell lymphoma with generalized skin lesions.
Masuda Y; Imura K; Sano Y; Yagi H
J Dermatol; 2024 Feb; 51(2):e53-e54. PubMed ID: 37752863
[No Abstract] [Full Text] [Related]
2. Primary cutaneous CD30-positive anaplastic large cell lymphoma in an 80-year-old man: a case report from Nepal.
Parajuli S; Gurung D; Paudel U; Pokhrel DB; Kempf W
Int J Dermatol; 2014 Dec; 53(12):1498-500. PubMed ID: 24738699
[No Abstract] [Full Text] [Related]
3. Primary cutaneous CD30+ lymphoproliferative disorder in an atopic dermatitis patient on cyclosporine therapy.
Nakamura S; Takeda K; Hashimoto Y; Mizumoto T; Ishida-Yamamoto A; Iizuka H
Indian J Dermatol Venereol Leprol; 2011; 77(2):253. PubMed ID: 21393977
[No Abstract] [Full Text] [Related]
4. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma.
Gupta I; Ramteke P; Narwal A; Sharma MC; Bakhshi S; Mallick S
Am J Dermatopathol; 2022 May; 44(5):376-379. PubMed ID: 35234192
[TBL] [Abstract][Full Text] [Related]
5. A case of primary cutaneous anaplastic large cell lymphoma on eyelid.
Gong Y; Chen J; Shi Y
Indian J Dermatol Venereol Leprol; 2022; 88(3):444. PubMed ID: 35389030
[TBL] [Abstract][Full Text] [Related]
6. CD30+ lymphoproliferative disorder in a patient with metastatic papillary thyroid carcinoma.
Udkoff J; Cohen PR
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329586
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.
Nakamura S; Hashimoto Y; Nishi K; Mizumoto T; Takahashi H; Iizuka H
Eur J Dermatol; 2012; 22(5):709-10. PubMed ID: 22929532
[No Abstract] [Full Text] [Related]
8. Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin.
Sasapu A; Dunn ALJ; Gardner J; Wong HK
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34290015
[TBL] [Abstract][Full Text] [Related]
9. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].
Slotosch CM; Hörster S; Hertl M; Schultz E
Hautarzt; 2010 Jun; 61(6):511-3. PubMed ID: 19536511
[TBL] [Abstract][Full Text] [Related]
10. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL
Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
[TBL] [Abstract][Full Text] [Related]
11. A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma.
Shah M; Pawar M; Zawar V
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):33-34. PubMed ID: 29589643
[TBL] [Abstract][Full Text] [Related]
12. CD30
Sauder MB; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Vonderheid EC; Sajjadian A; Kadin ME
J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous anaplastic large cell lymphoma in a 5-year-old child: A diagnostic challenge.
Capo A; Cinalli S; Angelucci D; Amerio P
Dermatol Ther; 2020 Nov; 33(6):e14195. PubMed ID: 32794314
[No Abstract] [Full Text] [Related]
15. Methotrexate-Associated B-Cell Lymphoproliferative Disease in a Patient With Cutaneous T-Cell Lymphoma.
Maderal AD; Malone JC; Callen JP
JAMA Dermatol; 2018 Apr; 154(4):490-492. PubMed ID: 29490369
[No Abstract] [Full Text] [Related]
16. Primary cutaneous anaplastic large-cell lymphoma--case report.
Oliveira LS; Nobrega MP; Monteiro MG; Almeida WL
An Bras Dermatol; 2013; 88(6 Suppl 1):132-5. PubMed ID: 24346900
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma.
Laly P; Ingen-Housz-Oro S; Beylot-Barry M; Verneuil L; Adamski H; Brice P; Bagot M
JAMA Dermatol; 2015 Sep; 151(9):1030-1. PubMed ID: 26108120
[No Abstract] [Full Text] [Related]
18. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
19. Low-dose Methotrexate Treatment for Solitary or Localized Primary Cutaneous Anaplastic Large Cell Lymphoma: A Long-term Follow-up Study.
Park JB; Yang MH; Kwon DI; Seong SH; Jang JY; Suh KS; Jang MS
Acta Derm Venereol; 2020 Feb; 100(4):adv00069. PubMed ID: 31996929
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate.
Fujita H; Nagatani T; Miyazawa M; Wada H; Koiwa K; Komatsu H; Ikezawa Z
Eur J Dermatol; 2008; 18(3):360-1. PubMed ID: 18474486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
